Qiagen
QGEN
#2513
Rank
C$10.02 B
Marketcap
C$48.60
Share price
0.80%
Change (1 day)
-15.41%
Change (1 year)

P/E ratio for Qiagen (QGEN)

P/E ratio as of May 2026 (TTM): 17.1

According to Qiagen 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 17.1158. At the end of 2024 the company had a P/E ratio of 111.

P/E ratio history for Qiagen from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024111321.69%
202326.410.03%
202224.08.63%
202122.0-26.91%
202030.2-118.28%
2019-165-551.21%
201836.6-77.16%
2017160123.3%
201671.765.77%
201543.37.74%
201440.1-41.6%
201368.7140.06%
201228.6

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Thermo Fisher Scientific
TMO
24.5 43.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
27.0 57.78%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
37.1 116.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
31.3 82.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
67.7 295.32%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.